The IPOX® Indexes


Discover the IPOX® Indexes

Our Philosophy

We classify New Listings—such as IPOs, Spin-offs, and M&As—as a distinct equity sector for a substantial period post-listing. Given the limited pre-public information, these New Listings often exhibit unique return patterns, including underpricing and short-term over-performance.

Our aim is to build portfolios that accurately track the performance of New Listings, reflecting economic growth and innovation, while minimizing turnover and structural risk.

The IPOX® Indexes offer a method for size, style, and sector allocation in global equities and are used as the basis for various financial products, including including Exchange Traded Funds (ETFs), Futures, Mutual Funds, Separately Managed Accounts (SMAs) and Structured Products.


For licensing enquiries, please contact: info@ipox.com  

IPOX® 100 U.S. Index

The IPOX® 100 U.S. Index (IPXO) is a modified value-weighted price index measuring the performance of the top 100 U.S. companies in the IPOX® Global Composite Index. The companies are ranked quarterly by market capitalization and the index uses a 10% capping on all constituents and includes the 100 largest, typically best performing and most liquid U.S. initial public offerings (“IPOs”). Read more…


IPOX® 100 Europe Index

The IPOX® 100 Europe Index (IPOE) is a modified value-weighted price index measuring the performance of the top 100 European and Europe-affiliated companies in the IPOX® Global Composite Index. The companies include listings from countries such as Germany, The Netherlands, The United Kingdom, Italy, France and the Nordic region. Read more…


IPOX® International Index

The IPOX® International Index (IPXI) is a modified value-weighted price index measuring the performance of the 50 largest and most liquid Non-US companies in the IPOX® Global Composite Index. The companies include listings from regions such as Europe, China, Japan and the Middle East. Read more…


IPOX® Global 50 Index

The IPOX® Global 50 Index (IPGL50) is an applied market cap-weighted index portfolio measuring the performance of the top 50 companies ranked monthly by market cap in the IPOX® Global Composite Index, subject to defined liquidity and exposure criteria. The index has historically captured ca. 50% total market cap created through Global New Listings activity over the past four years, respectively. Read more…


The IPOX® Canada Index

The IPOX® Canada Index (ICDX) is an applied market-cap weighted index measuring the performance of the top Newly Public Canadian companies primarily through IPO, Spin-off and IPO M&A. The index is reconstituted and readjusted quarterly.
Read more…


IPOX® Nordic Index

The IPOX® Nordic Index (IPND) is an applied market cap-weighted index portfolio measuring the performance of companies domiciled and traded in Denmark, Finland, Norway and Sweden ranked quarterly by market cap in the IPOX® Global Composite Index. Read more…


IPOX® MENA Index

The IPOX® MENA Index (IPEV) is an applied market cap-weighted index portfolio measuring the performance of companies domiciled and traded in the MENA region (e.g. United Arab Emirates, Saudi Arabia) ranked quarterly by market cap in the IPOX® Global Composite Index. Read more…


IPOX® Japan Index

The IPOX® Japan Index (IPJP) is an applied market cap-weighted index measuring the performance of the top Japan domiciled companies ranked quarterly in the IPOX® Global Composite Index. Read more…


IPOX® China Index

The IPOX® China Index (CNI) is an applied market cap-weighted index measuring the performance of the top 60 companies ranked quarterly in the IPOX® China Composite Index. Read more…


IPOX® SPAC Index

The IPOX® SPAC Index (SPAC) is designed to track the aftermarket performance of Special Purpose Acquisition Companies (SPACs) which pursued initial public offerings (IPO) in the U.S. The index is an applied market-cap weighted index measuring the performance of the top publicly traded SPACs. The index is actively reconstituted and adjusted. Read more…


IPOX® U.S. Composite Index

The IPOX® U.S. Composite Index (IPXC) is a dynamically re-balanced total market cap-weighted index portfolio measuring the performance of all U.S. listed New Listings by applying the IPOX® Indexes Technology. The IPOX® U.S. Composite Index has historically captured ca. 99% of total market cap created through New Listings by companies in the United States over the past four years, respectively.
Read more…


IPOX® U.S. ESG Index

The IPOX® U.S. ESG Index (IPXT) is an applied market cap-weighted index portfolio measuring the performance of the top 100 U.S. companies that have the highest environmental, social and governance (ESG) rating using an IPOX proprietary rating system. The index holdings are ranked quarterly by market cap in the IPOX® U.S. Composite Index, a sub-index of the IPOX® Global Composite Index – subject to defined liquidity and exposure criteria. Read more…


IPOX® Health Innovation Index

The IPOX® Health Innovation Index (IPHI) is a diverse and dynamic portfolio consisting of leading companies in the healthcare and biotechnology sectors. The index captures the performance of both established and emerging players focused on innovative solutions, novel therapies, and cutting-edge medical technologies. Read more…


IPOX® Bond Indexes

The IPOX® Bond Indexes are a series of innovative fixed income benchmarks that provide investors with targeted exposure to the corporate debt securities of companies in the IPOX® Universe, including New Listings (IPOs, Direct Listings, and Spin-offs) and firms that have acquired IPOX® holdings ("IPO M&A"). These indexes aim to capture the unique return dynamics and potential outperformance of bonds issued by these growth-oriented and innovative companies. Read more…


GINDEX® Growth Infusion Index

The GINDEX® Growth Infusion Index (GNDX) is an applied market-cap weighted index measuring the performance of companies that have previously acquired 100% Interest in a firm that has gone public through IPO, Direct Listing, and Spin-off in the United States (“IPO M&A”). Read more…


GINDEX® International Index

The GINDEX® Growth Infusion International Index (GNDXI) is an applied market-cap weighted index measuring the performance of companies that have previously acquired 100% Interest in a firm that has gone public through IPO, Direct Listing, and Spin-off in all world regions, except the U.S. (“IPO M&A”). Read more…


Diversified Portfolio Index

The Diversified Portfolio Index™ (DPXI) is a diversified portfolio allocation solution designed to capture all major asset classes, industry sectors, world geography and market capitalization. The DPIX™ is structured as a standard portfolio to contain ETFs (exchange traded funds) selected to represent all major asset classes with respective weightings include U.S. securities (40%), International stocks (10%), Bonds (30%), REITs (10%), Commodities (5%) and Precious Metals (5%).
IPOX® provides the benchmark publishing and services for the DPIX™ index.